論文・総説 - 稲澤　譲治

分割表示  519 件中 501 - 519 件目  ／  全件表示 >>

  1. Taniwaki M, Inazawa J, Horiike S, Misawa S, Abe T, Takino T. Karyotypic evolution in acute myelomonocytic leukemia with pericentric inversion of chromosome 16. Cancer Genet Cytogenet. 1987.02; 24 (2): 257-262. ( PubMed )

  2. Gen Yasuyuki, Inazawa Johji. Targeting super-enhancers by downregulating CBP and BRD4 using miR-766-5p-based cancer therapeutics CANCER SCIENCE. 2022.02; 113 1784.

  3. Kuroda Junya, Tsukamoto Taku, Kinoshita Masaki, Yamada Kazuhiro, Inazawa Johji. Imaging flow cytometry-based multiplex FISH for three IGH translocations for the precision medicine in multiple myeloma CANCER SCIENCE. 2022.02; 113

  4. Inoue Jun, Kishikawa Masahiro, Tsuda Hitoshi, Nakajima Yasuaki, Asakage Takahiro, Inazawa Johji. Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma CANCER SCIENCE. 2022.02; 113 1348.

  5. Muramatsu Tomoki, Inazawa Johji. Exploring the transcriptional inhibitors of VEGFA with chemical compound libraries CANCER SCIENCE. 2022.02; 113 850.

  6. Liu Chang, Gen Yasuyuki, Inazawa Johji. Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes resistance to BET inhibitors in neuroblastoma cells CANCER SCIENCE. 2022.02; 113 1785.

  7. 稲澤 譲治. FISH法の原理と応用　ゲノム医療実装化に向けての知識 組織細胞化学. 2021.08; 2021 97-106. ( 医中誌 )

  8. Inoue Jun, Gokita Kentaro, Kishikawa Masahiro, Hamamoto Hidetoshi, Kobayashi Katsunori, Fujiwara Kyoko, Asakage Takahiro, Kojima Kazuyuki, Inazawa Johji. Therapeutic potential of the topical treatment of miR-634 ointment for cutaneous squamous cell carcinoma CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  9. Muramatsu Tomoki, Sato Taku, Tanabe Minoru, Inazawa Johji. Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  10. Muramatsu Tomoki, Sato Taku, Tanabe Minoru, Inazawa Johji. Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  11. Inoue Jun, Gokita Kentaro, Kishikawa Masahiro, Hamamoto Hidetoshi, Kobayashi Katsunori, Fujiwara Kyoko, Asakage Takahiro, Kojima Kazuyuki, Inazawa Johji. Therapeutic potential of the topical treatment of miR-634 ointment for cutaneous squamous cell carcinoma CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  12. 井上 純, 稲澤 譲治. 【マイクロRNA研究の進歩】マイクロRNAを用いた核酸抗癌薬の開発 医学のあゆみ. 2019.05; 269 (5): 342-346. ( 医中誌 )

  13. 玄 泰行, 村松 智輝, 稲澤 譲治. 【膵胆道腫瘍におけるゲノム医療の現状と展望】膵癌におけるマイクロRNA研究の現状と治療への展望 胆と膵. 2019.04; 40 (4): 313-316. ( 医中誌 )

  14. Muramatsu Tomoki, Tonouchi Erina, Gen Yasuyuki, Hiramoto Hidekazu, Tanimoto Kousuke, Inoue Jun, Inazawa Johji. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein CANCER RESEARCH. 2018.07; 78 (13): ( DOI )

  15. Muramatsu Tomoki, Tonouchi Erina, Gen Yasuyuki, Hiramoto Hidekazu, Tanimoto Kousuke, Inoue Jun, Inazawa Johji. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein CANCER RESEARCH. 2018.07; 78 (13): ( DOI )

  16. 村松 智輝, 稲澤 譲治. 【がん転移学(上)-がん転移のメカニズムと治療戦略:その基礎と臨床-】がん転移学の基礎研究　In vivo選択法による高転移がん細胞亜株の分離 日本臨床. 2017.11; 75 (増刊8 がん転移学(上)): 130-136. ( 医中誌 )

  17. Ono H, Inazawa J. [DNA mismatch genes in colorectal cancer]. Nihon rinsho. Japanese journal of clinical medicine. 2011.04; 69 Suppl 3 77-83. ( PubMed )

  18. Inazawa J. [Cancer genomics in post-sequence era]. Nihon rinsho. Japanese journal of clinical medicine. 2005.12; 63 Suppl 12 42-9. ( PubMed )

  19. Imoto I, Inazawa J. [Exploration of novel molecular targets for cancer therapy based on genomic aberrations]. Gan to kagaku ryoho. Cancer & chemotherapy. 2005.11; 32 (12): 1891-4. ( PubMed )

< 前のページ - 次のページ >

このページの先頭へ▲